Immediate Impact

1 by Nobel laureates 1 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
2 intermediate papers

Works of Fernanda Musa being referenced

Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer
2016
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
2011

Author Peers

Author Last Decade Papers Cites
Fernanda Musa 292 241 86 184 38 532
Tapio Kuoppala 300 261 109 134 35 620
Mustafa Zelal Muallem 266 254 108 185 56 530
Margherita Fischetti 260 233 122 177 39 559
Kelly J. Manahan 164 231 107 181 45 548
Daniel Donato 170 268 137 165 29 524
Richard Slade 194 215 96 181 35 614
Carlos Chaves Faloppa 193 340 89 221 44 536
Bunja Rungruang 347 237 107 238 49 597
Scott E. Lentz 348 387 68 230 33 588
Dae Hoon Jeong 191 320 112 73 40 576

All Works

Loading papers...

Rankless by CCL
2026